Literature DB >> 3006071

A chimeric plasmid from cDNA clones of poliovirus and coxsackievirus produces a recombinant virus that is temperature-sensitive.

B L Semler, V H Johnson, S Tracy.   

Abstract

We have inserted a 405-nucleotide fragment from the 5' noncoding region of the coxsackievirus B3 genome into an infectious cDNA copy of the poliovirus RNA genome. Transfection of plasmid DNA containing this hybrid genome construct into cultured monkey cells produced infectious virus. Recombinant virus stocks displayed a temperature-sensitive phenotype for growth at 37 degrees C. We found that there is a dramatic reduction in the level of viral proteins and viral RNAs in HeLa cells infected with the recombinant at 37 degrees C compared to that obtained at 33.5 degrees C. Thus, insertion of a portion of the coxsackievirus genome into the poliovirus genome produces a temperature-sensitive recombinant virus. That this substitution occurs in a region of the poliovirus genome that, to date, has not been shown to have any coding function suggests that RNA sequences involved in replicase recognition or ribosome binding may contribute to the temperature-sensitive phenotype of the recombinant virus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3006071      PMCID: PMC323167          DOI: 10.1073/pnas.83.6.1777

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Molecular cloning and partial characterization of the coxsackievirus B3 genome. Brief report.

Authors:  S Tracy; N M Chapman; H L Liu
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

2.  A poliovirus temperature-sensitive RNA synthesis mutant located in a noncoding region of the genome.

Authors:  P Sarnow; H D Bernstein; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

3.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  The complete nucleotide sequence of a common cold virus: human rhinovirus 14.

Authors:  G Stanway; P J Hughes; R C Mountford; P D Minor; J W Almond
Journal:  Nucleic Acids Res       Date:  1984-10-25       Impact factor: 16.971

6.  Complete nucleotide sequences of all three poliovirus serotype genomes. Implication for genetic relationship, gene function and antigenic determinants.

Authors:  H Toyoda; M Kohara; Y Kataoka; T Suganuma; T Omata; N Imura; A Nomoto
Journal:  J Mol Biol       Date:  1984-04-25       Impact factor: 5.469

7.  Identification of the initiation site of poliovirus polyprotein synthesis.

Authors:  A J Dorner; L F Dorner; G R Larsen; E Wimmer; C W Anderson
Journal:  J Virol       Date:  1982-06       Impact factor: 5.103

8.  Regulation of simian virus 40 transcription: sensitive analysis of the RNA species present early in infections by virus or viral DNA.

Authors:  B A Parker; G R Stark
Journal:  J Virol       Date:  1979-08       Impact factor: 5.103

9.  The nucleotide and deduced amino acid sequences of the encephalomyocarditis viral polyprotein coding region.

Authors:  A C Palmenberg; E M Kirby; M R Janda; N L Drake; G M Duke; K F Potratz; M S Collett
Journal:  Nucleic Acids Res       Date:  1984-03-26       Impact factor: 16.971

10.  Simian virus 40 tandem repeated sequences as an element of the early promoter.

Authors:  P Gruss; R Dhar; G Khoury
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

View more
  29 in total

1.  Polioviruses containing picornavirus type 1 and/or type 2 internal ribosomal entry site elements: genetic hybrids and the expression of a foreign gene.

Authors:  L Alexander; H H Lu; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

2.  Limited expression of poliovirus by vaccinia virus recombinants due to inhibition of the vector by proteinase 2A.

Authors:  J E Jewell; L A Ball; R Rueckert
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

3.  Chimeric picornavirus polyproteins demonstrate a common 3C proteinase substrate specificity.

Authors:  P G Dewalt; M A Lawson; R J Colonno; B L Semler
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

4.  Effects of mutations in poliovirus 3Dpol on RNA polymerase activity and on polyprotein cleavage.

Authors:  C C Burns; M A Lawson; B L Semler; E Ehrenfeld
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

5.  Genetic variation occurring on the genome of an in vitro insertion mutant of poliovirus type 1.

Authors:  S Kuge; N Kawamura; A Nomoto
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

6.  The deletion of 41 proximal nucleotides reverts a poliovirus mutant containing a temperature-sensitive lesion in the 5' noncoding region of genomic RNA.

Authors:  S L Dildine; B L Semler
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

7.  Construction of viable deletion and insertion mutants of the Sabin strain of type 1 poliovirus: function of the 5' noncoding sequence in viral replication.

Authors:  S Kuge; A Nomoto
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

8.  Mutational analysis of the genome-linked protein VPg of poliovirus.

Authors:  R J Kuhn; H Tada; M F Ypma-Wong; B L Semler; E Wimmer
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

Review 9.  Picornavirus morphogenesis.

Authors:  Ping Jiang; Ying Liu; Hsin-Chieh Ma; Aniko V Paul; Eckard Wimmer
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

10.  Altered interactions between stem-loop IV within the 5' noncoding region of coxsackievirus RNA and poly(rC) binding protein 2: effects on IRES-mediated translation and viral infectivity.

Authors:  Polen Sean; Joseph H C Nguyen; Bert L Semler
Journal:  Virology       Date:  2009-05-14       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.